NVO - ENDRA Life Sciences' NASH Test Device TAEUS At Commercialization Inflection Point
ENDRA Life Sciences Inc. (NDRA) recently announced it is moving forward with the commercialization of its Thermo Acoustic Enhanced UltraSound (TAEUS) device in Europe. The TAEUS device is essentially a point of care ((POC)) or field diagnostic hybrid of an ultrasound and MRI that can monitor the progression of one of the largest unmet medical needs worldwide. Non-Alcoholic Steatohepatitis (NASH) or the early stage of the disease called Non-Alcoholic Fatty Liver Disease (NAFLD), affects over 1 billion people worldwide. In the wake of the COVID-19 pandemic, the one thing that we all learned about was